175 related articles for article (PubMed ID: 38486026)
1. Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma.
Wang Z; Zhang Y; Yang X; Zhang T; Li Z; Zhong Y; Fang Y; Chong W; Chen H; Lu M
Sci Rep; 2024 Mar; 14(1):6200. PubMed ID: 38486026
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
3. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma.
Zang B; Wang W; Wang Y; Li P; Xia T; Liu X; Chen D; Piao HL; Qi H; Ma Y
Front Mol Biosci; 2021; 8():721990. PubMed ID: 34568427
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect.
Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F
Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570
[TBL] [Abstract][Full Text] [Related]
6. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
[TBL] [Abstract][Full Text] [Related]
7. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
Hu D; Zhang M; Peng Z
J Cancer Res Ther; 2020 Sep; 16(5):1157-1164. PubMed ID: 33004764
[TBL] [Abstract][Full Text] [Related]
9. The metabolic genomic atlas reveals potential drivers and clinically relevant insights into the etiology of esophageal squamous cell carcinoma.
Liu X; Hong R; Du P; Yang D; He M; Wu Q; Li L; Wang Y; Chen J; Min Q; Li J; Zhang W; Zhan Q
Theranostics; 2022; 12(14):6160-6178. PubMed ID: 36168622
[No Abstract] [Full Text] [Related]
10. Functional characterization of a low-frequency V1937I variant in FASN associated with susceptibility to esophageal squamous cell carcinoma.
Wang X; Tian J; Zhao Q; Yang N; Ying P; Peng X; Zou D; Zhu Y; Zhong R; Gao Y; Chang J; Miao X
Arch Toxicol; 2020 Jun; 94(6):2039-2046. PubMed ID: 32388819
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression.
Liu H; Zhang Q; Song Y; Hao Y; Cui Y; Zhang X; Zhang X; Qin Y; Zhu G; Wang F; Dang J; Ma S; Zhang Y; Guo W; Li S; Guan F; Fan T
J Exp Clin Cancer Res; 2021 Sep; 40(1):287. PubMed ID: 34517880
[TBL] [Abstract][Full Text] [Related]
12. PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism.
Zhang GC; Yu XN; Guo HY; Sun JL; Liu ZY; Zhu JM; Liu TT; Dong L; Shen XZ; Yin J
Cancer Res; 2023 Feb; 83(4):521-537. PubMed ID: 36723974
[TBL] [Abstract][Full Text] [Related]
13. The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.
Zeng B; Zhang X; Zhao J; Wei Z; Zhu H; Fu M; Zou D; Feng Y; Luo H; Lei Y
BMC Cancer; 2019 Jun; 19(1):609. PubMed ID: 31226958
[TBL] [Abstract][Full Text] [Related]
14. Identification of Differentially Expressed Genes Related to the Lipid Metabolism of Esophageal Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
Cui MY; Yi X; Zhu DX; Wu J
Curr Oncol; 2022 Dec; 30(1):1-18. PubMed ID: 36661650
[TBL] [Abstract][Full Text] [Related]
15. ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy.
Wang T; Zhu Y; Chen L; Zhang W; Qi H; Shi X; Zhong M; Chen H; Li Q
J Transl Med; 2023 Sep; 21(1):605. PubMed ID: 37679788
[TBL] [Abstract][Full Text] [Related]
16. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
17. Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma.
Chu J; Niu X; Chang J; Shao M; Peng L; Xi Y; Lin A; Wang C; Cui Q; Luo Y; Fan W; Chen Y; Sun Y; Guo W; Tan W; Lin D; Wu C
Theranostics; 2020; 10(8):3488-3502. PubMed ID: 32206103
[No Abstract] [Full Text] [Related]
18. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma.
Wang X; Liu Y; Leng X; Cao K; Sun W; Zhu J; Ma J
Pathol Oncol Res; 2021; 27():632531. PubMed ID: 34257599
[No Abstract] [Full Text] [Related]
19. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
20. PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis.
Zhao M; Lu T; Bi G; Hu Z; Liang J; Bian Y; Feng M; Zhan C
Biomed Pharmacother; 2023 Dec; 168():115711. PubMed ID: 37879213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
